Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$157.72−4.84 (-2.98%)
Close on Nov 17, 2026Market cap $6.20BP/E –Yield –
Belite Bio total assets
Total assets on the balance sheet at the end of each period.
Belite Bio's total assets was $780.56M at Dec 31, 2025. For fiscal 2025 it was $780.56M, up 413.1% from the year before. The highest annual figure on record is $780.56M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $780.56M | +413.1% |
| FY2024 | Dec 31, 2024 | $152.13M | +60.7% |
| FY2023 | Dec 31, 2023 | $94.64M | +113.8% |
| FY2022 | Dec 31, 2022 | $44.27M | +141.3% |
| FY2021 | Dec 31, 2021 | $18.35M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $780.56M | +4154.2% |
| Q4 FY2024 | Dec 31, 2024 | $152.13M | – |
| Q4 FY2023 | Dec 31, 2023 | $94.64M | – |
| Q4 FY2022 | Dec 31, 2022 | $44.27M | – |
| Q4 FY2021 | Dec 31, 2021 | $18.35M | – |
See a number that looks wrong?